B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Felypressin

110 PubMed studies analyzed · 24 RCTs · Evidence Score: 52.7

Research Domains

Felypressin has been studied across 11 research domains including ❤️ Cardiovascular, 💊 Pain, 😴 Sleep, 🫘 Kidney, 🧠 Focus & Attention. The primary research focus is ❤️ Cardiovascular with 32% of studies addressing this area.

Loading evidence profile...

This evidence profile for Felypressin is generated deterministically from 110 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.